Cargando…
Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations
Autores principales: | Berges, Maja, Foster, Keith, Foster, Jennifer, Martinez, Lisa, Martinez, Sean, Fiedler, Benjamin, DeMets, David L., Maki, Dennis G., Hennekens, Charles H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802166/ https://www.ncbi.nlm.nih.gov/pubmed/35114173 http://dx.doi.org/10.1016/j.amjmed.2021.12.019 |
Ejemplares similares
-
Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19
por: Hennekens, Charles H., et al.
Publicado: (2022) -
Ivermectin in COVID-19: The Case for a Moratorium on Prescriptions
por: Molnar, Andreea, et al.
Publicado: (2022) -
Genomic surveillance to combat COVID-19: challenges and opportunities
por: Robishaw, Janet D, et al.
Publicado: (2021) -
Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
por: Shih, Richard D., et al.
Publicado: (2020) -
Data monitoring committees: history and their future
por: DeMets, David L
Publicado: (2013)